FDA: Baxter recalls two lots of IV solutions

Editor's Note

The Food and Drug Administration on January 5 announced that Baxter International, Inc (Deerfield, Illinois) is recalling two lots of IV solutions because of the presence of particulate matter. The particulate matter was determined to be an insect and was identified as a result of a customer complaint.

The recall affects:

• 0.9% sodium chloride Injection, USP, 250 mL Viaflex plastic container, lot number C980227
• 70% dextrose injection (2000 mL) USP, lot number C985150.

The lots being recalled were distributed between June 6 and December 16, 2015.

Includes: 0.9% Sodium Chloride Injection, USP, 250 mL VIAFLEX Plastic Container 70% Dextrose Injection (2000 mL) USP [Posted 01/05/2016] AUDIENCE: Pharmacy ISSUE: Baxter International Inc. announced a voluntarily recall of two lots of intravenous (IV) solutions to the hospital/end user level due to the potential presence of particulate matter.